Relafen 750, the unique formulation of naproxen, offers the compelling example from the biochemical pharmacy standpoint. This process of action, primarily involving suppression of cyclooxygenase enzymes – COX-1 and COX-2 – leads to the lowering in prostaglandin creation. From the biochemical context, it drug's potency is closely related to the